Xenetic Biosciences (XBIO) Return on Equity (2023 - 2025)
Xenetic Biosciences (XBIO) has disclosed Return on Equity for 5 consecutive years, with 0.79% as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Return on Equity fell 19.0% year-over-year to 0.79%, compared with a TTM value of 0.79% through Sep 2025, down 19.0%, and an annual FY2024 reading of 0.53%, changed N/A over the prior year.
- Return on Equity was 0.79% for Q3 2025 at Xenetic Biosciences, down from 0.68% in the prior quarter.
- Across five years, Return on Equity topped out at 0.15% in Q1 2023 and bottomed at 0.79% in Q3 2025.
- Average Return on Equity over 3 years is 0.51%, with a median of 0.6% recorded in 2024.
- The sharpest move saw Return on Equity crashed -46bps in 2024, then fell -6bps in 2025.
- Year by year, Return on Equity stood at 0.44% in 2023, then plummeted by -48bps to 0.64% in 2024, then decreased by -22bps to 0.79% in 2025.
- Business Quant data shows Return on Equity for XBIO at 0.79% in Q3 2025, 0.68% in Q2 2025, and 0.7% in Q1 2025.